Page last updated: 2024-10-30

meclofenoxate and Bipolar Disorder

meclofenoxate has been researched along with Bipolar Disorder in 1 studies

Meclofenoxate: An ester of DIMETHYLAMINOETHANOL and para-chlorophenoxyacetic acid.

Bipolar Disorder: A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence.

Research Excerpts

ExcerptRelevanceReference
"Meclofenoxate has been shown to increase cerebral cholinergic activity."1.27Meclofenoxate therapy in tardive dyskinesia: a preliminary report. ( Fukuda, T; Igata, A; Imamura, K; Izumi, K; Koja, T; Nomoto, M; Shimizu, T; Sonoda, H; Tominaga, H, 1986)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Izumi, K1
Tominaga, H1
Koja, T1
Nomoto, M1
Shimizu, T1
Sonoda, H1
Imamura, K1
Igata, A1
Fukuda, T1

Other Studies

1 other study available for meclofenoxate and Bipolar Disorder

ArticleYear
Meclofenoxate therapy in tardive dyskinesia: a preliminary report.
    Biological psychiatry, 1986, Volume: 21, Issue:2

    Topics: Administration, Oral; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Dyskinesia, Drug-Induced;

1986